Orthofix Medical Inc. revenue by segment OFIX

Orthofix Medical Inc. splits its revenue into 2 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Global Spine at $173.2 million, 82% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Jun 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Revenue
833
211
197
220
206
203
194
216
197
Global Spine
691
+1.7%
share 82.9%
173
+2.0%
share 82.1%
164
+0.0%
share 83.3%
182
+1.1%
share 82.7%
172
+3.6%
share 83.7%
170
share 83.6%
164
share 84.6%
180
share 83.4%
166
share 84.5%
Global Limb Reconstruction
142
+9.8%
share 17.1%
38
+13.2%
share 17.9%
33
+10.2%
share 16.7%
38
+6.2%
share 17.3%
34
+10.1%
share 16.3%
33
share 16.4%
30
share 15.4%
36
share 16.6%
31
share 15.5%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
OFIX (Nasdaq)
Fiscal year ends
December 23
Headquarters
Lewisville, TX
SEC filer status
Accelerated filer
SEC CIK
884624
Former names
ORTHOFIX INTERNATIONAL N V (until Aug 1, 2018)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.